Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study

NCT03733249 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Leukemia, Acute Myeloid (AML), Child
Lymphoma, Non-Hodgkin
Myelodysplastic Syndromes
Primary Immunodeficiency
Anemia, Aplastic
Hemoglobinopathies
Cytopenia
Fanconi Anemia
Diamond Blackfan Anemia
Thalassemia
Anemia, Sickle Cell

Interventions

DRUG: Rimiducid
BIOLOGICAL: rivogenlecleucel

Sponsor

Bellicum Pharmaceuticals